Comparison of analgesic effect of nebulized Ketamine versus intravenous Morphine in acute pain control

Phase 3

• Conditions: Pain.; Acute pain, not elsewhere classified; G89.1

• Registration Number: IRCT20220418054586N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

Acute pain in patients referred to the ER with a Visual analog scale (VAS) equivalent to or greater than 7 out of 10

Exclusion Criteria

Having a mental illness mentioned by the patient
Head trauma
Ischemic heart disease
Acute heart failure
Respiratory distress
Systolic blood pressure greater than 180 mmHg or less than 90 mmHg
Asthma
High intracranial pressure
Pregnancy
Addiction
Inability to describe the pain
Using other analgesics before admission
History of being allergic to Ketamine or Morphine or any contraindication of using these drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain level. Timepoint: Before intervention and in 5, 10, 20, 40, 60 minutes after intervetion. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: 60 minutes after receiving an intervention. Method of measurement: A questionnaire that includes possible side effects after receiving the drugs.